Clinical trial
The Effectiveness of USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in Improving Insulin Adherence, Glycemic Control and Inflammation
NCT05125185 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of USM-Insulin Adherence Module (U-IAM) for Type 2 Diabetes in Improving Insulin Adherence, Glycemic Control and Inflammation
- Lead sponsor
- Universiti Sains Malaysia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2021
- Completion date
- July 30, 2022
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes type 2 on insulin